Amdocs (DOX) | Financial Analysis & Statements
Amdocs Ltd. Mid-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.2B
Gross Profit
428.2M
37.04%
Operating Income
218.0M
18.86%
Net Income
158.5M
13.71%
EPS (Diluted)
$1.45
Balance Sheet Metrics
Total Assets
6.3B
Total Liabilities
2.9B
Shareholders Equity
3.5B
Debt to Equity
0.83
Cash Flow Metrics
Operating Cash Flow
210.7M
Free Cash Flow
187.9M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Amdocs Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.5B | 5.0B | 4.9B | 4.6B | 4.3B |
| Cost of Goods Sold | 2.8B | 3.2B | 3.2B | 3.0B | 2.8B |
| Gross Profit | 1.7B | 1.8B | 1.7B | 1.6B | 1.5B |
| Gross Margin % | 38.0% | 35.1% | 35.3% | 35.4% | 34.5% |
| Operating Expenses | |||||
| Research & Development | 340.8M | 360.8M | 374.9M | 354.7M | 312.9M |
| Selling, General & Administrative | 506.1M | 572.8M | 570.7M | 528.6M | 487.3M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 847.0M | 933.6M | 945.6M | 883.3M | 800.2M |
| Operating Income | 812.2M | 759.7M | 724.9M | 664.8M | 598.7M |
| Operating Margin % | 17.9% | 15.2% | 14.8% | 14.5% | 14.0% |
| Non-Operating Items | |||||
| Interest Income | 9.2M | 17.5M | 21.2M | 7.8M | 4.8M |
| Interest Expense | 42.4M | 34.9M | 23.1M | 16.9M | 21.3M |
| Other Non-Operating Income | -85.7M | -151.2M | -86.7M | -7.3M | 232.1M |
| Pre-tax Income | 693.2M | 591.1M | 636.4M | 648.4M | 814.3M |
| Income Tax | 125.5M | 94.8M | 93.4M | 98.9M | 125.9M |
| Effective Tax Rate % | 18.1% | 16.0% | 14.7% | 15.3% | 15.5% |
| Net Income | 567.8M | 496.3M | 543.0M | 549.5M | 688.4M |
| Net Margin % | 12.5% | 9.9% | 11.1% | 12.0% | 16.1% |
| Key Metrics | |||||
| EBITDA | 1.0B | 963.3M | 938.1M | 896.6M | 819.1M |
| EPS (Basic) | $5.08 | $4.27 | $4.52 | $4.47 | $5.36 |
| EPS (Diluted) | $5.05 | $4.25 | $4.49 | $4.44 | $5.32 |
| Basic Shares Outstanding | 111147000 | 115489000 | 119687000 | 122812000 | 128495000 |
| Diluted Shares Outstanding | 111147000 | 115489000 | 119687000 | 122812000 | 128495000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Amdocs Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 325.0M | 346.1M | 520.1M | 573.4M | 709.1M |
| Short-term Investments | 0 | 168.2M | 222.5M | 244.6M | 256.5M |
| Accounts Receivable | 589.8M | 665.7M | 733.0M | 789.6M | 704.5M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 331.4M | 228.5M | 224.6M | 238.4M | 235.1M |
| Total Current Assets | 1.6B | 1.8B | 1.9B | 2.0B | 2.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 182.1M | 149.3M | 160.9M | 176.9M | 233.2M |
| Goodwill | 5.9B | 5.9B | 5.7B | 5.5B | 5.5B |
| Intangible Assets | 156.3M | 160.7M | 181.5M | 178.3M | 259.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 660.1M | 704.5M | 631.6M | 574.9M | 630.7M |
| Total Non-Current Assets | 4.7B | 4.6B | 4.5B | 4.4B | 4.4B |
| Total Assets | 6.2B | 6.4B | 6.4B | 6.4B | 6.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 371.2M | 305.9M | 293.3M | 134.4M | 121.2M |
| Short-term Debt | 38.7M | 40.0M | 40.0M | 43.3M | 58.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 173.0M | 189.2M | 203.6M | 234.3M | 200.1M |
| Total Current Liabilities | 1.4B | 1.5B | 1.4B | 1.3B | 1.3B |
| Non-Current Liabilities | |||||
| Long-term Debt | 787.7M | 749.8M | 767.4M | 783.5M | 822.5M |
| Deferred Tax Liabilities | 218.8M | 197.9M | 252.6M | 312.2M | 304.5M |
| Other Non-Current Liabilities | 413.9M | 468.4M | 485.4M | 481.7M | 445.7M |
| Total Non-Current Liabilities | 1.4B | 1.4B | 1.5B | 1.6B | 1.6B |
| Total Liabilities | 2.8B | 2.9B | 2.9B | 2.8B | 2.9B |
| Equity | |||||
| Common Stock | 4.6M | 4.6M | 4.6M | 4.5M | 4.5M |
| Retained Earnings | 7.2B | 6.8B | 6.5B | 6.2B | 5.9B |
| Treasury Stock | 8.3B | 7.8B | 7.2B | 6.7B | 6.2B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.5B | 3.5B | 3.6B | 3.6B | 3.6B |
| Key Metrics | |||||
| Total Debt | 826.4M | 789.7M | 807.3M | 826.8M | 881.2M |
| Working Capital | 233.3M | 300.3M | 558.3M | 750.5M | 763.6M |
Balance Sheet Composition
Amdocs Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 567.8M | 496.3M | 543.0M | 549.5M | 688.4M |
| Depreciation & Amortization | 195.4M | 193.1M | 195.7M | 224.5M | 208.8M |
| Stock-Based Compensation | 104.9M | 104.5M | 89.7M | 71.8M | 54.2M |
| Working Capital Changes | -73.2M | 25.7M | 54.8M | -91.2M | 239.3M |
| Operating Cash Flow | 815.8M | 774.6M | 823.6M | 751.9M | 1.1B |
| Investing Activities | |||||
| Capital Expenditures | -104.0M | -105.5M | -124.4M | -227.2M | -210.4M |
| Acquisitions | -86.3M | -86.8M | -121.8M | -14.4M | 146.3M |
| Investment Purchases | 0 | -9.1M | 0 | -34.3M | -277.0M |
| Investment Sales | 170.0M | 68.7M | 26.0M | 21.9M | 18.2M |
| Investing Cash Flow | -2.1M | -127.4M | -224.5M | -262.5M | -329.0M |
| Financing Activities | |||||
| Share Repurchases | -551.3M | -563.1M | -489.5M | -508.5M | -680.0M |
| Dividends Paid | -224.4M | -212.0M | -199.5M | -186.1M | -177.5M |
| Debt Issuance | - | - | - | 0 | 0 |
| Debt Repayment | - | - | 0 | 0 | -100.0M |
| Financing Cash Flow | -789.4M | -798.0M | -700.1M | -712.8M | -960.0M |
| Free Cash Flow | 645.1M | 618.9M | 698.3M | 529.5M | 715.4M |
| Net Change in Cash | 24.3M | -150.8M | -101.0M | -223.5M | -148.3M |
Cash Flow Trend
Amdocs Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.60
Forward P/E
8.04
Price to Book
2.05
Price to Sales
1.53
PEG Ratio
1.41
Profitability Ratios
Profit Margin
12.47%
Operating Margin
18.86%
Return on Equity
16.48%
Return on Assets
8.16%
Financial Health
Current Ratio
1.06
Debt to Equity
27.48
Beta
0.47
Per Share Data
EPS (TTM)
$5.17
Book Value per Share
$31.82
Revenue per Share
$41.64
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| DOX | 7.0B | 12.60 | 2.05 | 16.48% | 12.47% | 27.48 |
| Microsoft | 3.1T | 26.56 | 8.06 | 34.39% | 39.04% | 31.54 |
| Oracle | 498.4B | 31.65 | 15.11 | 57.57% | 25.30% | 415.27 |
| DigitalOcean | 9.9B | 37.78 | -304.26 | -903.67% | 28.76% | -59.30 |
| Nutanix | 9.3B | 37.40 | -11.11 | -27.12% | 9.95% | -1.86 |
| Informatica | 7.6B | 826.33 | 3.12 | 0.43% | 0.62% | 75.61 |
Financial data is updated regularly. All figures are in the company's reporting currency.






